BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19062492)

  • 1. Totally implantable central venous access devices in adult oncological patients.
    Florio G; Del Papa M; Mari A; Carnì D
    Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgically implanted subcutaneous venous access devices in cancer patients.
    Repelaer van Driel OJ; Kuin CM; van de Velde CJ
    Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
    J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A total subcutaneously implantable venous catheter system. 4 years' experience in cancer patients].
    Ludwig R; Ludwig CU; Laffer U; Stoll HR; Obrecht JP
    Schweiz Med Wochenschr; 1988 Mar; 118(9):305-8. PubMed ID: 3358106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in venous access devices and nursing management strategies.
    Wickham RS
    Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable femoral vein catheters in cancer patients.
    Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
    Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable systems for intravenous drug delivery. Experiences in children with cancer.
    van der Staak F; Bökkerink J; Lippens R; Severijnen R
    Z Kinderchir; 1986 Feb; 41(1):39-42. PubMed ID: 3083618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of central venous access devices: outcome analysis of 2359 implantations].
    Stein M; Wagner RH
    Dtsch Med Wochenschr; 2005 May; 130(18):1129-32. PubMed ID: 15856394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A; Gatta C; Festini F
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefits of totally implanted central venous access in patients with cancer].
    Saito H; Kamada T; Sakurai Y; Hanawa M; Takamura A
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):519-24. PubMed ID: 1558403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
    Ge F; Cang J; Xue ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.